Samsung Biologics to buy its first US drug production facility from GSK for $280 million
SEOUL, Dec 22 (Reuters) - South Korea's Samsung Biologics said on Monday its U.S. unit is buying a U.S. drug production facility from GSK for $280 million. Samsung Biologics America is acquiring a...
Sun Dec 21 2025
